×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Shopping
Maps
Videos
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Quoin Pharmaceuticals to Announce First Quarter 2024 Financial Results on May 9, 2024
GlobeNewswire
ASHBURN, Va., May 02, 2024 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the “Company” or “Quoin”), a clinical stage...
1 day ago
Quoin Pharmaceuticals Provides Corporate Update and Announces Fourth Quarter and 2023 Financial Results
Yahoo Finance
Company reported positive initial clinical data for QRX003 from first six evaluable subjects in ongoing open-label Netherton Syndrome study...
1 month ago
Why Is Quoin Pharmaceuticals (QNRX) Stock Down 50% Today?
InvestorPlace
Quoin Pharmaceuticals stock is falling on Tuesday after the company announced the pricing of QNRX shares in a public offering.
1 month ago
Maxim Group Maintains Buy Rating for Quoin Pharmaceuticals: Here's What You Need To Know
markets.businessinsider.com
Maxim Group has decided to maintain its Buy rating of Quoin Pharmaceuticals (NASDAQ:QNRX) and lower its price target from $15.00 to $4.00.
1 month ago
Quoin Pharmaceuticals (NASDAQ:QNRX) Shares Down 1.8%
Defense World
Quoin Pharmaceuticals, Ltd. (NASDAQ:QNRX – Get Free Report)'s share price was down 1.8% on Thursday . The stock traded as low as $0.71 and...
2 weeks ago
Quoin Pharmaceuticals Announces FDA Clearance to Recruit Teen Subjects into Both Ongoing Netherton Syndrome ...
Yahoo Finance
Clearance to include teen patients in both the company's open label and placebo controlled studies expected to significantly expand the...
2 months ago
Crude Oil Down Over 1%; Quoin Pharmaceuticals Shares Spike Higher - BioCardia (NASDAQ:BCDA), BioVie ...
Benzinga
U.S. stocks traded lower toward the end of trading, with the S&P 500 edging lower on Monday. The Dow traded down 0.20% to 39007.30 while the...
2 months ago
Quoin stock soars 60% on FDA update for ichthyosis drug (NASDAQ:QNRX)
Seeking Alpha
Shares of Quoin Pharmaceuticals (NASDAQ:QNRX) soared 60% in morning trading Monday on news that the FDA has cleared the company to include...
2 months ago
Why Is Quoin Pharmaceuticals (QNRX) Stock Down 90% Today?
InvestorPlace
Why Is Quoin Pharmaceuticals (QNRX) Stock Down 90% Today? · Quoin Pharmaceuticals (QNRX) stock is dropping alongside an ADS ratio change. · The...
9 months ago
Quoin Pharmaceuticals Provides Corporate Update and Announces Third Quarter 2023 Financial Results
GlobeNewswire
Company reported positive clinical data for QRX003 from first six evaluable subjects in ongoing open-label Netherton Syndrome study Positive...
5 months ago